Thrivent Financial for Lutherans Sells 115,983 Shares of Sabra Healthcare REIT, Inc. $SBRA

Thrivent Financial for Lutherans reduced its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 12.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 830,523 shares of the real estate investment trust’s stock after selling 115,983 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.35% of Sabra Healthcare REIT worth $15,481,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Focus Partners Wealth increased its holdings in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Sabra Healthcare REIT by 23.6% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 12,748 shares of the real estate investment trust’s stock worth $237,000 after purchasing an additional 2,433 shares during the period. Ameritas Advisory Services LLC bought a new position in Sabra Healthcare REIT during the second quarter worth about $84,000. QRG Capital Management Inc. increased its stake in shares of Sabra Healthcare REIT by 8.9% in the second quarter. QRG Capital Management Inc. now owns 66,212 shares of the real estate investment trust’s stock worth $1,221,000 after purchasing an additional 5,416 shares in the last quarter. Finally, KLP Kapitalforvaltning AS raised its position in shares of Sabra Healthcare REIT by 7.4% in the second quarter. KLP Kapitalforvaltning AS now owns 49,500 shares of the real estate investment trust’s stock valued at $913,000 after purchasing an additional 3,400 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 0.5%

SBRA opened at $18.35 on Wednesday. The firm has a market capitalization of $4.58 billion, a P/E ratio of 25.49, a price-to-earnings-growth ratio of 1.27 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $19.97. The company has a fifty day moving average price of $19.03 and a 200-day moving average price of $18.71. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The company had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. During the same quarter last year, the business posted $0.37 earnings per share. The firm’s revenue was up 6.7% compared to the same quarter last year. Equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.5%. Sabra Healthcare REIT’s payout ratio is presently 166.67%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on SBRA. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Tuesday, January 20th. National Bankshares set a $22.00 target price on Sabra Healthcare REIT in a research report on Friday, October 17th. UBS Group assumed coverage on Sabra Healthcare REIT in a report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 price target for the company. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Four investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, Sabra Healthcare REIT presently has an average rating of “Hold” and an average price target of $21.11.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.